Johnson and Johnson 2009 Annual Report Download - page 26
Download and view the complete annual report
Please find page 26 of the 2009 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16 -
17 -
18 -
19 -
20 -
21 -
22 -
23 -
24 -
25 -
26 -
27 -
28 -
29 -
30 -
31 -
32 -
33 -
34 -
35 -
36 -
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
 |
 |
The Finance Committee
exercises the management
authority of the Board during
the intervals between Board
meetings. The Finance
Committee is comprised of the
Chairman of the Board and the
Presiding Director.
William C. Weldon, Chairman
James G. Cullen
The Nominating & Corporate
Governance Committee,
comprised entirely of
independent Directors, is
responsible for overseeing
corporate governance matters,
reviewing possible candidates
for Board membership and
recommending nominees for
election. The Committee is
also responsible for overseeing
the process for performance
evaluations of the Board and
its committees. Additionally,
the Committee reviews the
Company’s executive
succession plans and
executive resources.
Charles Prince, Chairman
James G. Cullen
Arnold G. Langbo
The Public Policy Advisory
Committee reviews the
Company’s policies, programs
and practices on public health
issues regarding the environ-
ment and the health and safety
of employees. The Committee
also reviews the Company’s
governmental aairs and
policies and other public policy
issues facing the Company.
The Committee advises and
makes recommendations
to the Board on these issues
as appropriate. The Public
Policy Advisory Committee
is comprised of independent
Directors and the Company’s
General Counsel and Vice
Presidents for Corporate Aairs,
Government Aairs and Policy,
and Worldwide Operations.
Leo F. Mullin, Chairman
Susan L. Lindquist, Ph.D.
William D. Perez
David Satcher, M.D., Ph.D.
Russell C. Deyo
Cliord E. Holland
Brian D. Perkins
Ajit Shetty, Ph.D.
The Science & Technology
Advisory Committee, comprised
of independent Directors and
the Company’s Vice President,
Science and Technology, advises
the Board on scientific
matters, including major
internal projects, interaction
with academic and other outside
research organizations,
and the acquisition of technolo-
gies and products.
David Satcher, M.D., Ph.D.,
Chairman
Mary Sue Coleman, Ph.D.
Michael M. E. Johns, M.D.
Susan L. Lindquist, Ph.D.
Garry A. Neil, M.D.
Chairman, Board of Directors
Chief Executive Ocer
Chairman, Executive Committee
Vice President, Finance
Chief Financial Ocer
Executive Committee
Corporate Controller
Vice President,
Chief Information Ocer
Vice President, General Counsel
Executive Committee
Worldwide Chairman,
Consumer Group
Executive Committee
Worldwide Chairman,
Medical Devices &
Diagnostics Group
Executive Committee
Vice President, Public Aairs &
Corporate Communication
Worldwide Chairman,
Pharmaceuticals Group
Executive Committee
Treasurer
Vice President,
Corporate Aairs
Secretary,
Associate General Counsel
The Executive Committee of
Johnson & Johnson is the
principal management
group responsible for the
operations and allocation of
the resources of the Company.
This Committee oversees and
coordinates the activities of the
Consumer, Pharmaceuticals
and Medical Devices and
Diagnostics business segments.
Each subsidiary within the
business segments is, with
some exceptions, managed by
citizens of the country where it
is located.
JOHNSON & JOHNSON 2009 ANNUAL REPORT24